Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis-Reference-Cited by-同舟云学术

Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis

Published:2013 Issue:4 Volume:14 Page:R34
ISSN:1465-6906
Container-title:Genome Biology
language:en
Short-container-title:Genome Biol

Author:

Nagalla Srikanth,Chou Jeff W,Willingham Mark C,Ruiz Jimmy,Vaughn James P,Dubey Purnima,Lash Timothy L,Hamilton-Dutoit Stephen J,Bergh Jonas,Sotiriou Christos,Black Michael A,Miller Lance D

Publisher

Springer Science and Business Media LLC

Reference78 articles.

1. A Cell Proliferation Signature Is a Marker of Extremely Poor Outcome in a Subpopulation of Breast Cancer Patients

2. Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer

3. From The Cover: An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

4. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

5. Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD8⁺ T cell‑related KCTD5 contributes to malignant progression and unfavorable clinical outcome of patients with triple‑negative breast cancer;Molecular Medicine Reports;2024-07-12

2. FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer;EMBO Molecular Medicine;2024-06-26

3. Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures;Molecular Oncology;2024-05-09

4. The VEGF-Hypoxia Signature Is Upregulated in Basal-like Breast Tumors from Women of African Ancestry and Associated with Poor Outcomes in Breast Cancer;Clinical Cancer Research;2024-04-02

5. Emerging measurements for tumor-infiltrating lymphocytes in breast cancer;Japanese Journal of Clinical Oncology;2024-03-23